A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ABT-199 in Female Patients With Systemic Lupus Erythematosus (SLE)

NCT01686555 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

97

Enrollment

INDUSTRY

Sponsor class

Conditions

Lupus Erythematosus

Interventions

DRUG: ABT-199
OTHER: Placebo

Sponsor

AbbVie (prior sponsor, Abbott)